/PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company founded on research from the Wellcome Trust Sanger Institute, announced... ...http://in.sys-con.com/node/3014232
(This March 13 story is corrected to make clear Circassia raised 200 million pounds, valuing it at 581 million) By Ben Hirschler and Caroline... ...http://in.reuters.com/article/2014/03/16/us-biotech-ipos-europe-idINBREA2F0PK20140316
London : Married women are 28 per cent less likely to die from heart disease than unmarried women, a new Oxford study has claimed. This is... ...http://www.deccanchronicle.com/140316/lifestyle-relationship/article/married-women-less-likely-die-heart-disease
The Clinical Research Facility is purpose-built to support advanced clinical trials, to benefit patients The University of Glasgow has received... ...http://www.indiainfoline.com/Markets/News/university-of-glasgow/5886652387
PRWeb 2014-03-14 Although over exposure to sunlight is one of the leading causes of skin cancer Chemist Direct reviews the benefits of daily... ...http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=170241
Radiation therapy (in American...